In agreement with this oncogenic potential, in vitro Cav1 knockdown of NSCLC cells has been shown to result in inhibition of cellular proliferation [15], whereas Cav1-overexpressing NSCLC cells, as well as anoikis-resistant cells, exhibit enhanced metastatic activity [16]. This evidence concerns the gene CAV1 and non-small cell lung carcinoma.